Real-world effectiveness of WHO recommended first-line antiretroviral therapies: a cohort study from a middle-income country-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Real-world effectiveness of WHO recommended first-line antiretroviral therapies: a cohort study from a middle-income country

Published:2023-03-31 Issue:12 Volume:35 Page:1891-1903
ISSN:0954-0121
Container-title:AIDS Care
language:en
Short-container-title:AIDS Care

Author:

Meireles Glaucia¹,Nobre Aline A.²,Cardoso Sandra W.³,Velasque Luciane⁴,Veloso Valdilea G.³,Grinsztejn Beatriz³,Luz Paula M.³^ORCID

Affiliation:

1. Escola Nacional de Saúde Pública, Fundação Oswaldo Cruz, Rio de Janeiro, Brazil

2. Programa de Computação Científica, Fundação Oswaldo Cruz, Rio de Janeiro, Brazil

3. Instituto Nacional de Infectologia Evandro Chagas, Fundação Oswaldo Cruz, Rio de Janeiro, Brazil

4. Centro de Ciências Exatas e Tecnologia, Universidade Federal do Estado do Rio de Janeiro, Rio de Janeiro, Brazil

Funder

Instituto Nacional de Infectologia Evandro Chagas

Conselho Nacional de Desenvolvimento Científico e Tecnológico

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior

Fundação de Amparo à Pesquisa do Estado do Rio de Janeiro

FAPERJ

NIH-funded Caribbean

CCASAnet

Publisher

Informa UK Limited

Subject

Public Health, Environmental and Occupational Health,Social Psychology,Health (social science)

Link

https://www.tandfonline.com/doi/pdf/10.1080/09540121.2023.2190954

Reference34 articles.

1. Ritonavir-Boosted Darunavir Plus Two Nucleoside Reverse Transcriptase Inhibitors versus Other Regimens for Initial Antiretroviral Therapy for People with HIV Infection: A Systematic Review

2. Age-associated predictors of medication adherence in HIV-positive adults: Health beliefs, self-efficacy, and neurocognitive status.

3. The Population Impact of Late Presentation With Advanced HIV Disease and Delayed Antiretroviral Therapy in Adults Receiving HIV Care in Latin America

4. Effectiveness of first-line antiretroviral therapy in the IPEC cohort, Rio de Janeiro, Brazil

5. Outcomes of second-line combination antiretroviral therapy for HIV-infected patients: a cohort study from Rio de Janeiro, Brazil

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3